Trial Profile
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Feb 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 20 Nov 2012 Planned end date changed from 1 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 23 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.